It has been reported that inhibition of SHP2 promotes mesenchymal-to-epithelial transformation in breast cancer cells (40), which was consistent with our current finding that SHP2 promoted EMT in lung epithelial cells. Here, PTPN11 is linked to breast carcinoma.